Masashi Nobunaga

1.8k total citations
83 papers, 1.5k citations indexed

About

Masashi Nobunaga is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Masashi Nobunaga has authored 83 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Rheumatology, 30 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Masashi Nobunaga's work include Rheumatoid Arthritis Research and Therapies (25 papers), Systemic Lupus Erythematosus Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Masashi Nobunaga is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Systemic Lupus Erythematosus Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Masashi Nobunaga collaborates with scholars based in Japan, United States and China. Masashi Nobunaga's co-authors include M Shingu, Masao Shingu, Masayuki Yasuda, Sakutaro Nonaka, Yutaka Nagai, Yoko Nagai, Kōji Yoshida, Nobuo Matsui, Shoichiro Irimajiri and Hiroshi Hashimoto and has published in prestigious journals such as Journal of Neuroscience, The Journal of Clinical Endocrinology & Metabolism and Annals of the Rheumatic Diseases.

In The Last Decade

Masashi Nobunaga

81 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Nobunaga Japan 23 490 432 322 165 165 83 1.5k
I Yaron Israel 21 378 0.8× 202 0.5× 209 0.6× 155 0.9× 301 1.8× 48 1.3k
Eugeniusz J. Kucharz Poland 20 327 0.7× 292 0.7× 283 0.9× 90 0.5× 98 0.6× 186 1.4k
Michael Seed United Kingdom 22 306 0.6× 327 0.8× 610 1.9× 325 2.0× 124 0.8× 53 1.9k
G. Smedegård Sweden 21 180 0.4× 488 1.1× 226 0.7× 97 0.6× 349 2.1× 47 1.5k
David Levartovsky Israel 24 726 1.5× 707 1.6× 460 1.4× 120 0.7× 420 2.5× 52 2.0k
M. Händel Germany 24 495 1.0× 383 0.9× 555 1.7× 231 1.4× 66 0.4× 62 2.4k
Ricardo Saban United States 26 260 0.5× 342 0.8× 481 1.5× 136 0.8× 383 2.3× 65 2.1k
Medha Rajappa India 25 227 0.5× 577 1.3× 383 1.2× 180 1.1× 169 1.0× 108 1.9k
Anne M. Pippen United States 23 307 0.6× 598 1.4× 870 2.7× 188 1.1× 406 2.5× 32 2.4k
Qiang Guo China 17 665 1.4× 320 0.7× 641 2.0× 271 1.6× 107 0.6× 48 2.0k

Countries citing papers authored by Masashi Nobunaga

Since Specialization
Citations

This map shows the geographic impact of Masashi Nobunaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Nobunaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Nobunaga more than expected).

Fields of papers citing papers by Masashi Nobunaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Nobunaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Nobunaga. The network helps show where Masashi Nobunaga may publish in the future.

Co-authorship network of co-authors of Masashi Nobunaga

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Nobunaga. A scholar is included among the top collaborators of Masashi Nobunaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Nobunaga. Masashi Nobunaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hara, Masako, Tohru Abe, Sachiko Sugawara, et al.. (2007). Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study. Modern Rheumatology. 17(1). 1–9. 49 indexed citations
2.
Nobunaga, Masashi, et al.. (2004). Relationship between Hotsprings and the Number of Aged People Needing Care. 67(4). 257–263. 1 indexed citations
3.
Yasuda, Masayuki, et al.. (1998). Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis. Clinical Rheumatology. 17(4). 311–317. 6 indexed citations
4.
5.
Tomooka, Katsuhiko, et al.. (1994). In vivo complement activation influencing complement profiles of rheumatoid arthritis patients without extra-articular symptoms. 5(2). 129–137. 1 indexed citations
6.
Yasuda, Miho, et al.. (1994). Additive two DMARD therapy of the patients with rheumatoid arthritis. Clinical Rheumatology. 13(3). 446–454. 6 indexed citations
7.
Shingu, M, et al.. (1994). Anti-inflammatory effects of recombinant human manganese superoxide dismutase on adjuvant arthritis in rats. Rheumatology International. 14(2). 77–81. 29 indexed citations
8.
9.
10.
Yamamoto, Masahiro, et al.. (1992). Intracellular signal transduction in proliferation of synovial cells. Clinical Rheumatology. 11(1). 92–96. 3 indexed citations
11.
Shingu, Masao, et al.. (1991). Inhibition of adjuvant arthritis by Kampo drugs.. Ensho. 11(3). 275–276. 1 indexed citations
12.
13.
Yamamoto, Masahiro, et al.. (1991). Effects of colony-stimulating factors on proliferation and activation of synovial cells. Clinical Rheumatology. 10(3). 277–282. 5 indexed citations
14.
SHINGU, MASAHISA, et al.. (1990). Effects of SH-group-containig compounds on neutrophil functions. International Journal of Immunopathology and Pharmacology. 3(1). 11–17. 1 indexed citations
15.
Shingu, M, et al.. (1989). Iron-binding proteins and free iron in synovial fluids of rheumatoid arthritis patients. Clinical Rheumatology. 8(3). 345–351. 30 indexed citations
16.
17.
Shingu, Masao, et al.. (1985). Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide. Inflammation. 9(3). 309–320. 74 indexed citations
18.
Shingu, Masao, et al.. (1983). Serum Factors from Patients with Systemic Lupus Erythematosus Enhancing Superoxide Generation by Normal Neutrophils. Journal of Investigative Dermatology. 81(3). 212–215. 25 indexed citations
19.
Shingu, Masao, et al.. (1982). Study on the mechanism of oxygen radical-induced inflammation. Ensho. 2(4). 367–368. 10 indexed citations
20.
Shingu, Masao & Masashi Nobunaga. (1981). Destruction of cultured endothelial cells by oxygen intermediates generated by granulocyte-serum interaction. Ensho. 1(2). 233–242. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I Yaron Breakdown of academic impact, for papers by Eugeniusz J. Kucharz Breakdown of academic impact, for papers by Michael Seed Breakdown of academic impact, for papers by G. Smedegård Breakdown of academic impact, for papers by David Levartovsky Breakdown of academic impact, for papers by M. Händel Breakdown of academic impact, for papers by Ricardo Saban Breakdown of academic impact, for papers by Medha Rajappa Breakdown of academic impact, for papers by Anne M. Pippen Breakdown of academic impact, for papers by Qiang Guo
Rankless by CCL
2026